Cargando…
Effect of communicating DNA based risk assessments for Crohn’s disease on smoking cessation: randomised controlled trial
Objective To test the hypothesis that communicating risk of developing Crohn’s disease based on genotype and that stopping smoking can reduce this risk, motivates behaviour change among smokers at familial risk. Design Parallel group, cluster randomised controlled trial. Setting Families with Crohn’...
Autores principales: | Hollands, Gareth J, Whitwell, Sophia C L, Parker, Richard A, Prescott, Natalie J, Forbes, Alastair, Sanderson, Jeremy, Mathew, Christopher G, Lewis, Cathryn M, Watts, Sally, Sutton, Stephen, Armstrong, David, Kinmonth, Ann Louise, Prevost, A Toby, Marteau, Theresa M |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group Ltd.
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3401124/ https://www.ncbi.nlm.nih.gov/pubmed/22822007 http://dx.doi.org/10.1136/bmj.e4708 |
Ejemplares similares
-
Trial Protocol: Communicating DNA-based risk assessments for Crohn's disease: a randomised controlled trial assessing impact upon stopping smoking
por: Whitwell, Sophia CL, et al.
Publicado: (2011) -
Effect on Adherence to Nicotine Replacement Therapy of Informing Smokers Their Dose Is Determined by Their Genotype: A Randomised Controlled Trial
por: Marteau, Theresa M., et al.
Publicado: (2012) -
Trial Protocol: Using genotype to tailor prescribing of nicotine replacement therapy: a randomised controlled trial assessing impact of communication upon adherence
por: Marteau, Theresa M, et al.
Publicado: (2010) -
Impact of an informed choice invitation on uptake of screening for diabetes in primary care (DICISION): trial protocol
por: Mann, Eleanor, et al.
Publicado: (2009) -
Impact of an informed choice invitation on uptake of screening for diabetes in primary care (DICISION): randomised trial
por: Marteau, Theresa M, et al.
Publicado: (2010)